Cargando…

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care

OBJECTIVE: To investigate net clinical benefit (NCB) of warfarin in individuals with atrial fibrillation (AF) across stroke risk and across primary and secondary care. METHODS: We conducted a linked electronic health record cohort study of 70 206 individuals with initial record of diagnosis of AF in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allan, Victoria, Banerjee, Amitava, Shah, Anoop Dinesh, Patel, Riyaz, Denaxas, Spiros, Casas, Juan-Pablo, Hemingway, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284481/ https://www.ncbi.nlm.nih.gov/pubmed/27580623 http://dx.doi.org/10.1136/heartjnl-2016-309910

Ejemplares similares

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014)

Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022)

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
por: Pol, Tymon, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
por: Emanuel, Subo, et al.
Publicado: (2023)

Digitally enabled acute care for atrial fibrillation: conception, feasibility and early outcomes of an AF virtual ward
por: Kotb, Ahmed, et al.
Publicado: (2023)

Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
por: Avezum, Alvaro, et al.
Publicado: (2018)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Association of income and health-related quality of life in atrial fibrillation
por: Guhl, Emily, et al.
Publicado: (2019)

Catheter ablation for the management of atrial fibrillation: current technical perspectives
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021)

Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
por: Kjerpeseth, Lars Jøran, et al.
Publicado: (2021)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation
por: Pius, Charlene, et al.
Publicado: (2022)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
por: Lehto, Mika, et al.
Publicado: (2022)

Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation
por: Parwani, Abdul Shokor, et al.
Publicado: (2017)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Quality of life and healthcare utilisation improvements after atrial fibrillation ablation
por: Gupta, Dhiraj, et al.
Publicado: (2021)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Characterising symptom clusters in patients with atrial fibrillation undergoing catheter ablation
por: Hobensack, Mollie, et al.
Publicado: (2023)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Development and validation of prediction models for incident atrial fibrillation in heart failure
por: Vinter, Nicklas, et al.
Publicado: (2023)

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
por: Morseth, Bente, et al.
Publicado: (2021)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
por: Higashiya, Shunichi, et al.
Publicado: (2017)

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
por: Gallagher, Celine, et al.
Publicado: (2020)

Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China
por: Du, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jn5nj8mlqivl3se4nqs1innkos